5 Tips To Avoid Personal Finance Trouble When Buying A Home

Read More

Fed announces interest-rate decision

Read More

BlackRock Finds More Risk Assets at Insurers Than ’08

Read More

One last single-story building on one last stretch of undeveloped downtown Denver land will soon be razed and replaced by two condo towers.

Over the weekend, Shelby’s Bar and Grill served its last beers at 519 18th St. The building that housed the bar for 28 years — and housed other bars going back more than 110 years — is getting torn down to make way for a 32- and 38-floor condo complex. BusinessDen first reported the news on Monday.

Amacon Development, based in Canada, bought Shelby’s and the land around it last year for $8.8 million. The developer hopes to break ground late this year or early next and open the first condo tower by 2022, Mark Sheldon, a Denver-based representative for Amacon, told The Denver Post.

Related Articles

Yates Tavern in Denver’s Berkeley neighborhood doesn’t have a liquor license yet, but it just moved one step closer

New bar Rita’s Law serving “cocktails and community” in Five Points. Oh, and food out of a school bus.

Cherry Creek’s lat..

0 0

A vacant former movie house in Denver’s Berkeley neighborhood inched closer to reopening as a concert hall and entertainment venue thanks to a city regulator’s recommendations.

Developer Ari Stutz, co-owner of the nearly century-old Yates Theater building at 4979 W. 44th Ave., went before city licensing authorities June 13 seeking a liquor license and cabaret license for the would-be venue. On Monday, Kimberley Chandler, an independent city hearing officer, recommended that Denver’s department of excise and licenses approve both requests.

Stutz made a case that “there is a need and desire” in the neighborhood for what the Yates Theater would bring, Chandler found. He also “made a good faith effort to address matters relating to possible nuisance issues” through an agreement struck with the Berkeley Regis United Neighbors organization, she wrote in her recommendation.

The theater inhabits a part of the city that is seeing rapid redevelopment and developer interest akin to what neighb..

0 0

Massachusetts pharmaceutical company CutisPharma Inc. has acquired Silvergate Pharmaceuticals Inc., creating a new, unified company called Azurity Pharmaceuticals, which will focus on meeting the needs of underserved patients, such as children and the elderly.

Silvergate, which develops pediatric medications, was co-founded by Michael Beckloff in 2010 after he and several area organizations saw a lack of safe and accurate medication for children. The Colorado-based company has its research-and-development…

0 0

Although specifics weren’t exactly spelled out — neither Highmark nor UPMC would release many details about the agreement and Shapiro wouldn’t either — it was unexpected but welcome news to western Pennsylvania.

0 0

Mike Grey four years ago sold Lumena Pharmaceuticals Inc. — including two drugs targeting liver diseases — to Shire plc. On Friday, his new Peninsula company filed for an $86.25 million initial public offering to take those same two drugs deeper into the clinical trials.

Mirum Pharmaceuticals Inc., a 24-employee company in Foster City, said in a Securities and Exchange Commission filing that it expects to use the money to complete a late-stage clinical trial of the drug maralixibat and start…

0 0

The White House will release an executive order on Monday, June 24, 2019, intended to require insurance companies, doctors and hospitals to give patients more information about precisely what their care will cost before they get it.

0 0

A St. Louis law firm with a track record of success in class-action lawsuits has filed one in Missouri against Monsanto Co., claiming illegal and misleading advertising of its Roundup weed killer.

St. Louis-based Gray, Ritter & Graham and a Kansas City firm filed the suit June 20 in Jackson County Circuit Court, contending that the advertising violated Missouri law.

The suit seeks refunds for all purchases of Roundup by Missouri residents, as well as punitive damages and attorneys’ fees. The…

0 0

Blue Cross and Blue Shield of Minnesota and North Memorial Health have launched a joint venture company that splits ownership of North Memorial's 20 primary and specialty care clinics in the Twin Cities between the two organizations, an action that echoes the growing affinity between payers and providers across the country.

Eagan-based Blue Cross and Robbinsdale-based North Memorial announced the new venture Monday. As part of the agreement, North Memorial will own 51 percent of the new company,…

0 0

Florida-based Haskell makes a strategic investment in Locally-based company BLOX

0 0

Bartell hopes to expand to seven locations by the fall, and 128-year-old drugstore has gotten positive feedback from its early users.

0 0